GPCR · NASDAQ · Biotechnology

Structure Therapeutics (ADR) (GPCR)

Develops oral small-molecule medicines for metabolic, cardiovascular, and pulmonary conditions.

$37.20
After-hours close+0.38 (+1.03%)
At close$36.82(+0.03%)